Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Frank Roberts

Principal, Health & Life Sciences, Oliver Wyman

Rapid Cost Transformation to Establish a Baseline

Sixty-five percent of health plans with total membership in group commercial are at high-risk for negative profitability.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner, Financial Services, Oliver Wyman
Senior Consultant, Oliver Wyman

Cost Transformation Amidst Uncertainty

Establish and aim towards a North Star to ensure your organization heads in the direction you want it to.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Cost as an Investment (Not an Inconvenience)

But it's always been done this way. Until now.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

20 percent of care is unnecessary. Peer physician assessment of practice patterns is helping solve healthcare's inappropriate care crisis.

Principal, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman

Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.

Global Head, Health Services, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Transparency into peer practices may curb care overuse. But just prescribing fewer antibiotics isn't a simple solution.

Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights into how hospital systems can manage Medicaid populations without abandoning their mission – or their bottom line.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

To what extent could intelligent analytic tools impact healthcare providers in the future?

Principal, Health & Life Sciences, Oliver Wyman